Testing effectiveness (Phase 2)Study completedNCT01363297What this trial is testingStudy Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia Pfizer 72
Early research (Phase 1)Study completedNCT01321346What this trial is testingPanobinostat In Children With Refractory Hematologic MalignanciesWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more Therapeutic Advances in Childhood Leukemia Consortium 30
Early research (Phase 1)Looking for participantsNCT06863259What this trial is testingStudy of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Children's Hospital Medical Center, Cincinnati 28
Early research (Phase 1)Active Not RecruitingNCT04606433What this trial is testingPhase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic Leukemia Sichuan Baili Pharmaceutical Co., Ltd. 47
Very early researchLooking for participantsNCT06696833What this trial is testingAllogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Adult The First Affiliated Hospital of Soochow University 18
Not applicableStudy completedNCT00919425What this trial is testingS9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Study completedNCT01702155What this trial is testingPhase I/II Study of DFP-10917 in Patients With Acute LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic Leukemia Delta-Fly Pharma, Inc. 69
Early research (Phase 1)Study completedNCT03181126What this trial is testingVenetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic LymphomaWho this might be right forAcute Lymphoblastic Leukemia (ALL)Lymphoblastic Lymphoma AbbVie 69
Very early researchWithdrawnNCT07196111What this trial is testingBAFFR CAR-T Treatment for Relapsed/Refractory B-cell TumorsWho this might be right forB Acute Lymphoblastic Leukemia/Lymphoma Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)Study completedNCT00077467What this trial is testingBortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004009What this trial is testingR115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaWho this might be right forLeukemia University of Maryland, Baltimore
Early research (Phase 1)WithdrawnNCT05521087What this trial is testingJNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWho this might be right forAcute LeukemiasAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more Janssen Research & Development, LLC
Large-scale testing (Phase 3)Not Yet RecruitingNCT07774377What this trial is testingChidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/LymphomaWho this might be right forT-Cell Acute Lymphoblastic LeukemiaT-Cell Lymphoblastic Lymphoma First Affiliated Hospital of Zhejiang University 132
Not applicableEnded earlyNCT01326728What this trial is testingRelapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forChronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more National Cancer Institute (NCI) 56
Early research (Phase 1)Active Not RecruitingNCT03740334What this trial is testingRibociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLWho this might be right forAcute Lymphoblastic Leukemia ALL Dana-Farber Cancer Institute 45
Early research (Phase 1)Ended earlyNCT01551043What this trial is testingAllo CART-19 ProtocolWho this might be right forAcute Lymphocytic Leukemia University of Pennsylvania 2
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Early research (Phase 1)Active Not RecruitingNCT04872790What this trial is testingVenetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Mixed Phenotype Acute Leukemia+2 more OHSU Knight Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT05667506What this trial is testingCNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)Who this might be right forB-cell Acute Lymphoblastic Leukemia Juventas Cell Therapy Ltd. 47
Early research (Phase 1)Looking for participantsNCT06326008What this trial is testingSafety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical TrialWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse Beijing GoBroad Hospital 48